IL227696A0 - A method for the discovery of pharmacogenomic biomarkers - Google Patents
A method for the discovery of pharmacogenomic biomarkersInfo
- Publication number
- IL227696A0 IL227696A0 IL227696A IL22769613A IL227696A0 IL 227696 A0 IL227696 A0 IL 227696A0 IL 227696 A IL227696 A IL 227696A IL 22769613 A IL22769613 A IL 22769613A IL 227696 A0 IL227696 A0 IL 227696A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmacogenomic biomarkers
- discovering
- discovering pharmacogenomic
- biomarkers
- pharmacogenomic
- Prior art date
Links
- 239000000090 biomarker Substances 0.000 title 1
- 230000002974 pharmacogenomic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
- C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/40—Population genetics; Linkage disequilibrium
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Pathology (AREA)
- Physiology (AREA)
- Ecology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161437788P | 2011-01-31 | 2011-01-31 | |
| PCT/US2012/023195 WO2012106267A1 (en) | 2011-01-31 | 2012-01-30 | Method for discovering pharmacogenomic biomarkers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL227696A0 true IL227696A0 (en) | 2013-09-30 |
Family
ID=45563619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL227696A IL227696A0 (en) | 2011-01-31 | 2013-07-29 | A method for the discovery of pharmacogenomic biomarkers |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20140031242A1 (enExample) |
| EP (1) | EP2707498B1 (enExample) |
| JP (3) | JP2014506459A (enExample) |
| KR (1) | KR102006417B1 (enExample) |
| CN (2) | CN107475371B (enExample) |
| AU (1) | AU2012212499A1 (enExample) |
| CA (1) | CA2826109A1 (enExample) |
| IL (1) | IL227696A0 (enExample) |
| MX (1) | MX2013008846A (enExample) |
| SG (1) | SG192202A1 (enExample) |
| WO (1) | WO2012106267A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104965998B (zh) * | 2015-05-29 | 2017-09-15 | 华中农业大学 | 多靶标药物和/或药物组合的筛选方法 |
| KR102415328B1 (ko) * | 2015-12-03 | 2022-06-30 | 삼성전자주식회사 | 전기적 특성을 개선할 수 있는 에스램 소자 및 이를 포함하는 로직 소자 |
| JP2019501524A (ja) * | 2015-12-04 | 2019-01-17 | ザ・シランナ・グループ・プロプライエタリー・リミテッドＴｈｅ Ｓｉｌａｎｎａ Ｇｒｏｕｐ Ｐｔｙ Ｌｉｍｉｔｅｄ | 絶縁体上半導体基板 |
| US20170329914A1 (en) * | 2016-05-11 | 2017-11-16 | International Business Machines Corporation | Predicting Personalized Cancer Metastasis Routes, Biological Mediators of Metastasis and Metastasis Blocking Therapies |
| JOP20190025A1 (ar) * | 2016-09-01 | 2019-02-19 | Denovo Biopharma Llc | طرق وتركيبة لتوقع نشاط إنزاستورين |
| KR102302847B1 (ko) | 2016-11-01 | 2021-09-15 | 스미토모 덴키 고교 가부시키가이샤 | 초전도 선재 |
| CN108108592B (zh) * | 2017-12-29 | 2020-06-16 | 北京聚道科技有限公司 | 一种用于遗传变异致病性打分的机器学习模型的构建方法 |
| CN109872792A (zh) * | 2019-04-16 | 2019-06-11 | 北京中佰耀因医药科技有限公司 | 一种用于指导精准用药的基因检测智能报告系统 |
| CN110010200A (zh) * | 2019-04-16 | 2019-07-12 | 长沙三济生物科技有限公司 | 一种基因身份识别系统 |
| CN109994156A (zh) * | 2019-04-16 | 2019-07-09 | 北京中佰耀因医药科技有限公司 | 一种含报告模板信息管理模块的精准用药智能报告系统 |
| CN110010222A (zh) * | 2019-04-16 | 2019-07-12 | 长沙三济生物科技有限公司 | 一种基于精准用药知识库的基因身份识别系统 |
| CN109994180A (zh) * | 2019-04-16 | 2019-07-09 | 北京中佰耀因医药科技有限公司 | 一种含基因位点信息管理模块的精准用药智能报告系统 |
| CN109994176A (zh) * | 2019-04-16 | 2019-07-09 | 北京中佰耀因医药科技有限公司 | 一种含样本类型信息管理模块的精准用药智能报告系统 |
| CN109979545A (zh) * | 2019-04-16 | 2019-07-05 | 北京中佰耀因医药科技有限公司 | 一种含样本状态信息管理模块的精准用药智能报告系统 |
| IL296168A (en) | 2020-03-06 | 2022-11-01 | Denovo Biopharma Llc | Preparations and methods for evaluating the effectiveness of inhibitors of neurotransmitter transporters |
| US20250270627A1 (en) * | 2021-10-22 | 2025-08-28 | Illumina, Inc. | Genotyping Methods and Systems |
| CN119832990B (zh) * | 2024-12-19 | 2025-09-16 | 公安部第一研究所 | 一种利用slsqp分析二混dna的混合比例方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101191143B (zh) * | 2006-11-22 | 2012-05-23 | 上海生物芯片有限公司 | 无需核酸标记的基因芯片及其检测方法和应用 |
| US7790396B1 (en) * | 2009-12-23 | 2010-09-07 | Suregene, Llc | Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype |
-
2012
- 2012-01-30 KR KR1020137023254A patent/KR102006417B1/ko not_active Expired - Fee Related
- 2012-01-30 US US13/982,470 patent/US20140031242A1/en not_active Abandoned
- 2012-01-30 MX MX2013008846A patent/MX2013008846A/es not_active Application Discontinuation
- 2012-01-30 WO PCT/US2012/023195 patent/WO2012106267A1/en not_active Ceased
- 2012-01-30 JP JP2013551420A patent/JP2014506459A/ja not_active Withdrawn
- 2012-01-30 AU AU2012212499A patent/AU2012212499A1/en not_active Abandoned
- 2012-01-30 EP EP12702740.7A patent/EP2707498B1/en active Active
- 2012-01-30 CN CN201710590820.4A patent/CN107475371B/zh active Active
- 2012-01-30 SG SG2013057658A patent/SG192202A1/en unknown
- 2012-01-30 CN CN201280002881XA patent/CN103270176A/zh active Pending
- 2012-01-30 CA CA2826109A patent/CA2826109A1/en not_active Abandoned
-
2013
- 2013-07-29 IL IL227696A patent/IL227696A0/en unknown
-
2016
- 2016-08-02 JP JP2016151735A patent/JP6440658B2/ja not_active Expired - Fee Related
-
2018
- 2018-06-27 JP JP2018121765A patent/JP2018148930A/ja not_active Withdrawn
-
2020
- 2020-12-21 US US17/129,054 patent/US20210108266A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN107475371A (zh) | 2017-12-15 |
| CN103270176A (zh) | 2013-08-28 |
| CN107475371B (zh) | 2021-06-11 |
| US20210108266A1 (en) | 2021-04-15 |
| JP2016214257A (ja) | 2016-12-22 |
| AU2012212499A1 (en) | 2013-08-22 |
| JP6440658B2 (ja) | 2018-12-19 |
| CA2826109A1 (en) | 2012-08-09 |
| EP2707498B1 (en) | 2018-01-17 |
| JP2018148930A (ja) | 2018-09-27 |
| EP2707498A1 (en) | 2014-03-19 |
| KR20140040700A (ko) | 2014-04-03 |
| JP2014506459A (ja) | 2014-03-17 |
| MX2013008846A (es) | 2014-02-11 |
| KR102006417B1 (ko) | 2019-08-01 |
| SG192202A1 (en) | 2013-08-30 |
| US20140031242A1 (en) | 2014-01-30 |
| WO2012106267A1 (en) | 2012-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL227696A0 (en) | A method for the discovery of pharmacogenomic biomarkers | |
| PL3543333T3 (pl) | Sposób badania przesiewowego alfa-amylaz | |
| EP2698464A4 (en) | WASHING METHOD | |
| PL2780470T3 (pl) | Metoda wykonywania oznaczeń ilościowych | |
| GB201113087D0 (en) | Method | |
| GB201120527D0 (en) | Method | |
| ZA201400772B (en) | Method for using vinasse | |
| GB201116530D0 (en) | Method | |
| GB201117477D0 (en) | Method | |
| GB201105436D0 (en) | Method | |
| PL2476684T3 (pl) | Sposób wytwarzania alkilofosforanów | |
| GB201119867D0 (en) | Method | |
| GB201112447D0 (en) | Method | |
| GB201121301D0 (en) | Method | |
| GB201114919D0 (en) | Method | |
| GB201114325D0 (en) | Method | |
| GB201101219D0 (en) | Method | |
| GB201117476D0 (en) | Method | |
| GB201111673D0 (en) | Method | |
| GB201111189D0 (en) | Method | |
| PL2476685T3 (pl) | Sposób wytwarzania alkilofosforanów | |
| GB201117358D0 (en) | Method | |
| GB201115783D0 (en) | Method | |
| GB201108041D0 (en) | Method | |
| PL395545A1 (pl) | Sposób otrzymywania modyfikowanych oligosilseskwioksanów klatkowych |